ID23804A - Treatment of diabetes with insulin secretagogues thiazolidinediones and alpha-glucosidase inhibitors - Google Patents

Treatment of diabetes with insulin secretagogues thiazolidinediones and alpha-glucosidase inhibitors

Info

Publication number
ID23804A
ID23804A IDW20000077A ID20000077A ID23804A ID 23804 A ID23804 A ID 23804A ID W20000077 A IDW20000077 A ID W20000077A ID 20000077 A ID20000077 A ID 20000077A ID 23804 A ID23804 A ID 23804A
Authority
ID
Indonesia
Prior art keywords
thiazolidinediones
diabetes
alpha
treatment
glucosidase inhibitors
Prior art date
Application number
IDW20000077A
Other languages
Indonesian (id)
Inventor
Robin Edwin Buckingham
Stephen Alistair Smith
Original Assignee
Smithkline Beecham Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to GB9715298A priority Critical patent/GB9715298D0/en
Application filed by Smithkline Beecham Plc filed Critical Smithkline Beecham Plc
Publication of ID23804A publication Critical patent/ID23804A/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/702Oligosaccharides, i.e. having three to five saccharide radicals attached to each other by glycosidic linkages
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445Non condensed piperidines, e.g. piperocaine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/64Sulfonylureas, e.g. glibenclamide, tolbutamide, chlorpropamide
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K45/00Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
IDW20000077A 1997-07-18 1998-07-16 Treatment of diabetes with insulin secretagogues thiazolidinediones and alpha-glucosidase inhibitors ID23804A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
GB9715298A GB9715298D0 (en) 1997-07-18 1997-07-18 Novel method of treatment

Publications (1)

Publication Number Publication Date
ID23804A true ID23804A (en) 2000-05-11

Family

ID=10816170

Family Applications (1)

Application Number Title Priority Date Filing Date
IDW20000077A ID23804A (en) 1997-07-18 1998-07-16 Treatment of diabetes with insulin secretagogues thiazolidinediones and alpha-glucosidase inhibitors

Country Status (27)

Country Link
EP (1) EP1001784A1 (en)
JP (1) JP2001510160A (en)
KR (1) KR20010021952A (en)
CN (1) CN1263467A (en)
AP (1) AP200001735A0 (en)
AR (2) AR016350A1 (en)
AU (1) AU8449098A (en)
BG (1) BG104062A (en)
BR (1) BR9810292A (en)
CA (1) CA2297133A1 (en)
CO (1) CO4940489A1 (en)
DZ (1) DZ2563A1 (en)
EA (1) EA200000140A1 (en)
GB (1) GB9715298D0 (en)
HU (1) HU0003626A3 (en)
ID (1) ID23804A (en)
IL (1) IL133907D0 (en)
MA (1) MA24608A1 (en)
NO (1) NO20000230D0 (en)
OA (1) OA11312A (en)
PE (1) PE99499A1 (en)
PL (1) PL338140A1 (en)
SK (1) SK612000A3 (en)
TR (1) TR200000133T2 (en)
UY (1) UY25101A1 (en)
WO (1) WO1999003478A1 (en)
ZA (1) ZA9806364B (en)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW438587B (en) * 1995-06-20 2001-06-07 Takeda Chemical Industries Ltd A pharmaceutical composition for prophylaxis and treatment of diabetes
PT1133312E (en) 1999-06-21 2007-11-30 Lilly Co Eli Synergistic use of thiazolidinediones with glucagon-like peptide-1 and agonists thereof to treat non-insulin dependent diabetes
WO2001052825A2 (en) * 2000-01-21 2001-07-26 Novartis Ag Combinations comprising dipeptidylpeptidase-iv inhibitors and antidiabetic agents
JP4917712B2 (en) * 2000-02-24 2012-04-18 武田薬品工業株式会社 Concomitant medication
EP1295609A4 (en) * 2000-02-24 2004-11-03 Takeda Chemical Industries Ltd Drugs containing combined active ingredients
WO2002055009A1 (en) 2001-01-12 2002-07-18 Sun Pharmaceutical Industries Limited Spaced drug delivery system
FR2832930A1 (en) * 2001-12-03 2003-06-06 Lipha Pharmaceutical composition comprising an alpha-glucosidase inhibitor and a thiazolidinedione derivative and use thereof for the preparation of medicaments for the treatment of diabetes
WO2005041962A1 (en) 2003-10-31 2005-05-12 Takeda Pharmaceutical Company Limited Solid preparation comprising an insulin sensitizer, an insulin secretagogue and a polyoxyethylene sorbitan fatty acid ester
CN101103993B (en) 2006-07-14 2011-03-30 北京华安佛医药研究中心有限公司 Hypoglycemic medicine composition

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1993003724A1 (en) * 1991-08-26 1993-03-04 The Upjohn Company Pharmaceutical composition containing 3-guanidinopropionic acid and pioglitazone glibenclamide or glimepiride
US5917052A (en) * 1994-09-28 1999-06-29 Shaman Pharmaceuticals, Inc. Hypoglycemic agent from cryptolepis
TW438587B (en) * 1995-06-20 2001-06-07 Takeda Chemical Industries Ltd A pharmaceutical composition for prophylaxis and treatment of diabetes

Also Published As

Publication number Publication date
CO4940489A1 (en) 2000-07-24
HU0003626A2 (en) 2001-05-28
WO1999003478A1 (en) 1999-01-28
JP2001510160A (en) 2001-07-31
PL338140A1 (en) 2000-09-25
EA200000140A1 (en) 2000-06-26
GB9715298D0 (en) 1997-09-24
BR9810292A (en) 2000-09-19
CN1263467A (en) 2000-08-16
AR019724A2 (en) 2002-03-13
AP200001735A0 (en) 2000-03-31
TR200000133T2 (en) 2000-09-21
NO20000230L (en) 2000-01-17
AR016350A1 (en) 2001-07-04
IL133907D0 (en) 2001-04-30
HU0003626A3 (en) 2001-12-28
UY25101A1 (en) 2000-12-29
AU8449098A (en) 1999-02-10
KR20010021952A (en) 2001-03-15
ZA9806364B (en) 2000-01-17
OA11312A (en) 2003-10-24
NO20000230D0 (en) 2000-01-17
MA24608A1 (en) 1999-04-01
EP1001784A1 (en) 2000-05-24
DZ2563A1 (en) 2003-02-15
CA2297133A1 (en) 1999-01-28
SK612000A3 (en) 2000-07-11
BG104062A (en) 2000-11-30
PE99499A1 (en) 1999-12-18

Similar Documents

Publication Publication Date Title
DE69813274D1 (en) Catheter for perfusion and okklusion
DE69902106T2 (en) Surface treatment of fluorinated contact lens materials
DE69330521D1 (en) Radioactively-labeled peptide derivatives of somatostatin to the image-forming and therapeutic use
DE69333672D1 (en) Recombinant lipase and alpha-amylase variants
DE69531394D1 (en) Surface treatment of polymeric
DE69530004D1 (en) Transdermal administration of apomorphine
DZ1719A1 (en) drug injectors and methods of use.
DE852949T1 (en) Use of alpha-amino acids to promote the desmosomal degradation or desquamation of the stratum corneum
DE69822713D1 (en) Indwelling catheter and Herstellungsmetode
DE69527955D1 (en) Treatment of glucans with enzymes
DE69827402D1 (en) Chemical cleaning of biological material
FI963968A0 (en) Contact adhesive (s) and section below (s)
DE69426210T2 (en) Transdermal iontophoretic delivery of drugs in micro-carriers
DE69731736D1 (en) Injection treatment for mastery of muscle spasms and pain associated
DE69822160D1 (en) Improved injection syringe
AT234945T (en) Stainless steel austenoferritischer with very low nickel content and high tensile
DE69709714T2 (en) Device for non-invasive determination of glucose
ID24653A (en) Therapeutic substances
IS6154A (en) Materials for prevention of and treatment mýlildis
IS6170A (en) Materials for prevention of and treatment mýlildis
DE69704513T2 (en) Assembly consisting of syringe and needle guard
DE69902391T2 (en) Noninvasive transdermal detection of analytes
IT1219552B (en) enzyme electrode and electrode module as well as' on the method of use
EE9900030A (en) And the gene of the HPPD inhibitors
DK0811430T3 (en) Water repellent surface treatment with acid activation